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Study question: What does this document on the surgical treatment of endometriosis jointly prepared by the
European Society for Gynaecological Endoscopy (ESGE), ESHRE, and the World Endometriosis Society (WES) provide?
Summary answer: This document provides recommendations covering technical aspects of different methods of
surgery for endometriomas in women of reproductive age.
What is already known: Endometriomas (ovarian endometriotic cysts) are a commonly diagnosed form of
endometriosis, owing to the relative ease and accuracy of ultrasound diagnosis. They frequently present a
clinical dilemma as to whether and how to treat them when found during imaging or incidentally during
surgery. Previously published guidelines have provided recommendations based on the best available
evidence, but without technical details on the management of endometriosis.
Study design, size and duration: A working group of ESGE, ESHRE and WES collaborated on writing
recommendations on the practical aspects of endometrioma surgery.
Participants/materials, setting and methods: This document focused on endometrioma surgery. Further
documents in this series will provide recommendations for surgery of deep and peritoneal endometriosis.
Main results and the role of chance: The document presents general recommendations for surgery of
endometrioma and specific recommendations for cystectomy, ablation by laser or by plasma energy, electrocoagulation
and a combination of these techniques applied together or with an interval between them.
Limitations and reasons for caution: Owing to the limited evidence available, recommendations are mostly based on
clinical expertise.
Wider implications of the findings: These recommendations complement previous guidelines on the management of
endometriosis.
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This paper was produced by a European working group
looking at the different types of surgery for endometriosis,
a common condition where tissue, which is similar to the
lining of the womb, is found elsewhere in the body.
The working group looked specifically at how best to
treat a type of ovarian cyst called an endometrioma, which
can occur in women who have endometriosis. Drug ther-
apies may be used to treat endometriosis, but when endo-
metriomas are found and need treatment, surgery is often
used. There are risks associated with surgery as it can
damage the follicles in the ovaries and reduce fertility.
The working group looked at the main types of surgery
which are used to treat endometriomas in women who
may want to have children in the future. They considered
cystectomy, where the cyst is cut out, ablation, where the
cyst lining is removed by using a laser beam or plasma en-
ergy, and electrosurgery, where an electric current is used.
They also looked at the effectiveness of combining different
types of surgery.
The paper discusses in detail how different types of sur-
gery should be performed taking potential risks into consid-
eration and stresses that careful planning is essential to
ensure the best outcomes.Introduction
Endometriosis is a common inflammatory condition af-
fecting women, mostly during their reproductive years
[3]. Endometriosis can be asymptomatic, but associated
symptoms include abdominal pain, painful periods, dys-
pareunia, dyschezia and infertility. As such, endometri-
osis not only has a significant impact on the lives of
millions of women and their families, but also is associ-
ated with an enormous socioeconomic burden [15, 19].
It is generally accepted that endometriosis presents in
three different entities, which are frequently found to-
gether: peritoneal lesions, deep endometriosis and ovarian
endometriotic cysts (endometriomas) [14]. Endometrio-
mas are probably the most commonly diagnosed form of
endometriosis because of the relative ease and accuracy of
ultrasound diagnosis. Although their exact prevalence and
incidence are not known, they have been reported in 17–
44% of women with endometriosis [4]. The presence of
ovarian endometriomas has been reported as being a
marker for deep endometriosis [16] and multifocal deep
vaginal, intestinal and ureteric lesions [5].
The pathogenesis of endometriomas remains contentious,
with a variety of theories proffered, including invagination
and subsequent collection of menstrual debris from endo-
metriotic implants, which are located on the ovarian surface
and adherent peritoneum [2, 10], colonisation of functional
ovarian cysts by endometriotic cells [12] and coelomic
metaplasia of the invaginated epithelial inclusions [14].Endometriomas frequently present a clinical dilemma
as to whether and how to treat them when found during
imaging. Overall, currently available treatment options
for all types of endometriosis include oestrogen suppres-
sion, progestins, surgery or a combination of these [8].
Surgical treatment is the mainstay of endometrioma
management when treatment is required, aimed at the
elimination of endometriotic tissue, to provide sufficient
tissue for histological assessment and to preserve a max-
imum amount of normal ovarian tissue (where fertility is
desired and/or risk of menopause is to be avoided). It
has been shown that surgical treatment of endometriotic
cysts is associated with the unintentional removal or de-
struction of ovarian follicles, which can be objectified by
a measurable post-operative reduction in serum anti-
Müllerian hormone (AMH) levels or antral follicle count
(AFC) on ultrasound [1, 20].Materials and methods
Previously published guidelines have provided recom-
mendations on the management of endometriosis, based
on the best available evidence [7, 11, 22]. However, these
guidelines were not intended to provide recommenda-
tions on the technical details of surgical procedures.
Therefore, the European Society for Gynaecological En-
doscopy (ESGE), the European Society of Human
Reproduction and Embryology (ESHRE) and the World
Endometriosis Society (WES) have formed a working
group to provide a series of recommendations on the
practical aspects of the different surgical procedures for
the treatment of endometriosis.
This document is the first in a series of recommenda-
tions covering technical aspects of different methods of
surgery for different entities of endometriosis and will
focus on endometriomas in women of reproductive age;
recommendations dealing with other forms of endomet-
riosis will be addressed in separate subsequent publica-
tions. These recommendations should be read in
conjunction with the aforementioned evidence-based
guidelines on the clinical management of endometriosis.
Owing to the scarcity of evidence, these recommenda-
tions are mostly based on expert opinion on best clinical
practice. The techniques described here may have differ-
ent levels of efficacy in achieving individualised manage-
ment goals; hence, background factors such as the
woman’s age, her symptoms (pain, infertility), primary aim
of the treatment (eliminating/improving pain, improving
fertility, ruling out malignancy), ovarian reserve, unilater-
ality/bilaterality, number and size(s) of the cyst(s), associ-
ated conditions (deep endometriosis, uterine or ovarian
abnormalities and in infertile couples: tubal status and
male factor) and history of previous surgery (i.e. recur-
rence) will need to be taken into consideration when a
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chosen.
In addition to the recommendations, the working group
has set up a web platform with videos on the different op-
tions available for surgery of ovarian endometrioma. The
web platform is accessible through the following link




Endometriomas are frequently stuck densely to sur-
rounding structures such as the ipsilateral pelvic side
wall, the fallopian tube, the posterolateral uterus and the
bowel. As part of preoperative planning, the surgeon
should consider the possibility of hydro-ureters and
asymptomatic hydronephrosis. The ureter enters the
small pelvis by crossing the iliac vessels and then courses
anteriorly in the peritoneum of the pelvic side wall dir-
ectly under the ovary. Ovaries with endometriotic cysts
are usually adherent to the ovarian fossa, where the ur-
eter may also be involved in the disease. Occasionally,
ureteric obstruction can be seen at this point. This will
need to be taken into account during surgery.
The ovary receives its blood supply from two sources:
the ovarian artery, which arises from the abdominal aorta
below the renal artery and laterally approaches the ovary
through the suspensory ovarian (infundibulopelvic) liga-
ment, and an anastomosis between the ovarian artery and
the ascending branch of the uterine artery/tubal artery in
the ovarian ligament. Thus, the larger intra-ovarian vessels
are found in the anterolateral aspect of the ovary—the
hilum at the insertion of the mesovarium. The surgeon
needs to be aware of this and, in particular for endome-
trioma involving that area, has to possess the skills to
avoid excessive bleeding which might lead to destruction
of healthy ovarian tissue through cauterisation and disrup-
tion of ovarian blood supply.
General recommendations
 Assess the possible extent of disease and the size,
number and location (unilateral or bilateral) of the
ovarian endometriotic cysts before surgery.
Meticulous preoperative planning is part of the
procedure and should include:
 A bimanual examination to check adnexal masses
and endometriotic nodules
 Pelvic ultrasound (and/or MRI) to determine
 The number, size and location (unilateral or
bilateral) of the cysts
 Presence of endometriotic nodules
 Extent of the Pouch of Douglas obliteration
 Presence of hydronephrosis Presence of hydrosalpinx
 Ovarian reserve tests (AFC, AMH) when future
fertility is a concern
 Assess serum tumour markers in case of suspicion
of malignancy at imaging, as this may be helpful to
exclude malignancy. The risk of unexpected
malignancy is small but may need to be taken into
consideration. The accuracy of serum tumour
markers may be limited as some of these are raised
in the presence of endometriosis [13].
 Obtain appropriate consent from the woman before
surgery. She should be fully informed of all possible
risks associated with the surgical procedure,
including general risks of laparoscopic surgery, a
potentially reduced ovarian reserve, and the (albeit
small) risk of loss of the ovary and consequences
thereof. Although still controversial, the woman
should also be informed about the possibility of
preoperative freezing of oocytes, especially in the
case of bilateral disease [21].
 Refer the woman to a centre of expertise where the
necessary surgical expertise is available, if the
surgery cannot be performed or completed safely
[11].
 Handle the ovarian tissue as atraumatically as
possible.
 Be aware of the risk of damage to ovarian reserve in
endometrioma surgery. Fertility preservation should
be considered when the reserve is already
compromised.
 Consider using anti-adhesion measures such as
oxidised regenerated cellulose, polytetrafluoroethylene
surgical membrane and hyaluronic acid products, as
these may be beneficial in reducing postoperative
adhesion formation [7, 22]. Ovarian suspension could
be an alternative method of adhesion prevention [9].
Initial stages of laparoscopic surgery for ovarian
endometriomas
 Inspect the pelvic organs, upper abdomen and
appendix.
 Obtain peritoneal washings and biopsies before
mobilising the ovary with endometrioma in the
presence of clinically relevant ascites, suspicious
peritoneal lesions or ovarian cysts of abnormal
appearance. However, for a presumed
endometrioma, peritoneal washing is not routinely
recommended.
 Consider using three laparoscopic working ports as
these may facilitate surgery.
 Separate the ovary with endometrioma from the
pelvic side wall, where it is usually adherent to, by
adhesiolysis. This usually results in drainage of the
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at this stage to avoid damage, as the ovary may be
adherent to it. In the presence of dense adherence,
start the surgery by dissecting the ureter from the
healthy tissue proximal to the adherence point.
Endometriotic tissue on the pelvic side wall will
need to be removed as well (this will be covered in
the subsequent recommendation on the treatment
of peritoneal endometriosis).
 Where the cyst ruptures, extend the opening in the
cyst wall adequately to expose the cyst cavity.
Multiple incisions and excessive opening should be
avoided to prevent damaging the ovarian cortex,
functional ovarian tissue and the hilum. Where
feasible, the cyst may be turned inside out to
facilitate further treatment.
 When the ovary is not adherent, the incision should
ideally be over the thinnest part of the ovarian
endometriotic surface or, if this is not visible, on the
antimesenteric border.
 Irrigate and inspect the cyst cavity to rule out
malignancy. Any suspicious area should be biopsied
for histological confirmation of any diagnosis.
 If suspicious for malignancy, local guidelines for
further management should be followed.
 Irrigate and aspirate thoroughly to check for
haemostasis and to remove any remaining cyst fluid
or blood clots from the abdominal-pelvic cavity.
The following options are available for conservative
surgical treatment of ovarian endometrioma:
 Cystectomy
 Ablation by laser or by plasma energy
 Electrocoagulation
These methods, the combined technique and the two-
or three-step approach are described below.
Cystectomy
 After mobilisation of the ovary and drainage of the
cyst, make an incision to reveal the cleavage plane;
this may be either on the edge of the cyst opening
or a central incision, which divides the cyst into two
halves. With both approaches, the incision should be
away from the blood vessels in the hilum/meso-
ovarium. Use of cold cut at the edge of the cyst
opening may assist in identifying the cleavage plane.
 To aid dissection and identification of the cyst wall,
saline or diluted synthetic vasopressin solution (0.1–
1 unit/ml) may be injected under the cyst capsule.
The diluted synthetic vasopressin injection has the
additional advantage of reduced bleeding during cystremoval. Synthetic vasopressin is not available in all
countries and, although rare, may cause
intraoperative cardiovascular complications
including bradycardia and hypertension.
 In some cases, a cleavage plane may not easily be
identified after the ovarian incision. In such cases, it
may be better to take a small part of the cyst wall
for histological diagnosis and then use an ablation
method, rather than risking damage to the ovary
from persistent attempts to perform cystectomy.
 Once the cleavage plane is identified, use gentle
traction and counter-traction with appropriate
instruments to dissect the cyst capsule from the
ovarian parenchyma. Traction and counter-traction
may be effective during the initial part of the
dissection. Avoid use of excessive force to separate a
highly adherent cyst from the ovary, as this will
likely cause tearing of the ovarian tissue, excessive
bleeding, plus the need for coagulation or diathermy,
and thus further damage the normal ovarian tissue.
 Careful identification of the cleavage plane and
precise spot bipolar coagulation is the key to achieve
haemostasis, to prevent unnecessary damage to
healthy tissue and to avoid blind or excessive
diathermy.
 Ensure final haemostasis after complete removal of
the cyst capsule. Bipolar coagulation, suturing or
intraovarian haemostatic sealant agents may also be
used for this purpose. It is important to avoid
damaging the major blood supply at the hilum
coming in from the ovarian and infundibulopelvic
ligaments at this stage.
 After removal of large endometriomas, it may be
necessary to reconstruct the ovary and achieve
haemostasis with monofilament sutures. For small
endometriomas, suturing is often not required as the
ovarian opening usually approximates spontaneously.
If a suture is used, it should ideally be placed inside
the ovary, as the exposed suture may be prone to
adhesion formation.
 Small cyst walls may be divided and retrieved
directly through a port. Large cyst walls can be
removed in a specimen retrieval bag. Posterior
colpotomy is very rarely used for retrieval of
endometriomas.
Laser ablation
 Ablate the entire inner surface of the cyst wall using
the laser beam. Power settings of 30–55 W for CO2
laser beam and 6–10 W for CO2 fibre (based on
animal data) are usually used. The laser should be
on the ablate function to widen the beam (e.g.
‘defocus’ or ‘surgiscan’). The laser should be applied
Table 1 Principles of electrosurgery for endometrioma
Electrosurgery application
The thickness of the capsule of an endometrioma can be up to 3.0 mm
and varies between cysts, but may also change within the same cyst.
During
the application of HF energy for destruction of an endometriotic lesion
by a thermal effect, it is difficult to assess the changes in the tissue.
Whereas the impact on superficial tissue may be visible by change of
colour and vaporisation, coagulation of deeper structures is more
difficult to observe. The surgeon needs to be aware of the exact HF
effect of each instrument and various application forms. Coagulation or
vaporisation of the ovarian cyst should inactivate endometriotic lesions
superficially and respect the underlying tissue. Uncontrolled application
of heat or deep coagulation may result in destruction of healthy tissue,
primordial follicles and/or blood supply of the ovary, with severe
consequences for ovarian function.
Monopolar energy
Cutting current is unmodulated alternating current, and vaporises or cuts
the tissue for superficial ablation and deeper coagulation effect.
Coagulation current is modulated alternating high voltage current and
has a higher thermal spread, which leads to deeper coagulation of the
tissue. Blended current is a mixture of cutting and coagulation currents,
and is generated by altering the time that the current is applied. The
more concentrated the energy, the greater is the thermodynamic effect.
Current density depends on the size of the electrode (a smaller
electrode may require a lower power setting). Use of monopolar
diathermy, with a low power setting and small contact surface, provides
better control of the tissue effect.
Argon beam coagulation
With this instrument, ionised argon gas carries electrons from the
electrode to the tissue. The gas stream produces a monopolar tissue
effect depending on the diameter of the beam and the distance
between the beam and the target. The tissue effect is similar to that
achieved by monopolar coagulation, but allows treatment of wider
superficial areas.
Bipolar energy
Bipolar diathermy is a very useful technique to coagulate endometriosis
in a safer way than monopolar diathermy. The current passes across the
tissue between the two jaws of the instrument. The tissue temperature
could be up to 300 400°C at the point of maximum current flow. The
penetration into the tissue can be up to 10 12 mm, depending on the
power setting and the application time.
Saridogan et al. Gynecological Surgery  (2017) 14:27 Page 5 of 7in such a mode that it can ablate the tissue while
preserving the underlying healthy tissue.
 Aim to vaporise the endometriotic cyst lining only
until haemosiderin pigment-stained tissue is no lon-
ger visible (until the colour changes from reddish to
yellow-white). The entire depth of the cyst capsule
does not need vaporisation, as endometriotic tissue
is present only superficially.
 Use intermittent irrigation to maintain good
visibility and to remove carbon debris.
 Ensure the border of the cyst opening is completely
vaporised.
Plasma energy ablation
 Ablate the entire inner surface of the cyst wall using
plasma energy in coagulation mode set at 10 to 40,
at a distance averaging 5 mm from the tip of the
hand piece [17, 18].
 Aim to vaporise the endometriotic cyst lining only
until haemosiderin pigment-stained tissue is no lon-
ger visible (until the colour changes from reddish to
yellow-white). The entire depth of the cyst capsule
does not need vaporisation, as endometriotic tissue
is present only superficially.
 Take care to treat all areas and to ablate the edges
of the invagination site.
 When cyst eversion is not feasible, expose the cyst
interior progressively to apply the plasma at an angle
perpendicular to the inner surface of the cyst.
Electrocoagulation
Electrosurgery is widely used for the treatment of ovar-
ian endometrioma. Coagulation modes with different
techniques and electrodes lead to different voltage levels,
including modulation of high-frequency (HF) current
with soft coagulation, forced coagulation or spray coagu-
lation. These various application modes result in differ-
ent effects on the target tissue and cause different
degrees of tissue damage (Table 1).
 Coagulate the cyst lining systematically using bipolar
forceps. The power setting depends on the generator
and type of forceps used, but a 25–40 W setting is
frequently used. It is advisable to start at a lower
power setting and adjust it depending on the
effectiveness of coagulation achieved. The key point
is to use very short coagulation times to minimise
ovarian tissue damage, as the depth of the
destruction can be difficult to judge.
 Monopolar energy may be used in selected areas
where there is fibrotic endometriotic tissue located
at the hilum. A power setting of 15–20 W is
frequently used. Tissue damage tends to be deeper than with laser
and plasma energy ablation; hence, the ovary should
be cooled frequently with irrigation fluid.Combined technique
A combined technique using both excision and ablation
can be used to prevent excessive bleeding and ovarian
tissue removal/damage from the ovarian hilum, particu-
larly for larger endometriomas.
 Open and drain the cyst followed by identification of
the cleavage plane, as described above.
 Strip 80–90% of the cyst wall and perform a partial
cystectomy, as described above, up to the ovarian
hilum. Laser, plasma energy or bipolar can then be
applied to treat the remaining endometriotic tissue
(10–20%).
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anatomy.Two- or three-step approach for large endometriomas
For large endometriomas, a two- or three-step proced-
ure can be considered.
 The first step involves opening and draining the
endometrioma as described in the initial stage
section.
 Inspect the cyst cavity and take a biopsy.
 Following this initial step, administer a GnRH
agonist (GnRHa) therapy for 3 months, during
which time the thickness of the cyst wall
significantly decreases, with atrophy and reduction
in stromal vascularisation of the cyst [6].
 Complete the surgery with a second laparoscopy in
the form of either cystectomy, CO2 vaporisation,
bipolar diathermy or plasma ablation of the cyst wall
lining.
Although women have to undergo two invasive proce-
dures, the potential benefit is that this may facilitate the
management of larger ovarian endometriomas, reduce
recurrence rates and limit decrease in ovarian reserve.Further considerations
Laparotomy is rarely indicated for benign ovarian endo-
metriomas, regardless of the diameter of the cyst and/or
the associated adhesions [11]. If the procedure is too diffi-
cult to perform by laparoscopy, it is better to stop the pro-
cedure after the drainage of the endometrioma(s),
prescribe GnRHa for 3 months, and re-operate 3–
6 months later. Alternatively, the woman may be referred
to a centre with the necessary surgical expertise [11].
Oophorectomy may be considered after careful discus-
sion with the woman, particularly in the presence of re-
current or large unilateral endometriomas, or suspicion
of potential malignancy. Informed consent, as described
above, needs to be obtained in all cases, and fertility
concerns need to be discussed.
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